HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 479 filers reported holding HORIZON THERAPEUTICS PUB L in Q3 2023. The put-call ratio across all filers is 2.95 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $55,354 | -22.2% | 478,470 | -30.8% | 0.25% | -18.0% |
| Q2 2023 | $71,139 | -69.6% | 691,679 | -67.8% | 0.30% | -16.0% |
| Q1 2023 | $234,294 | +192.7% | 2,146,743 | +205.2% | 0.36% | -1.1% |
| Q4 2022 | $80,058 | -99.8% | 703,500 | -1.7% | 0.36% | +71.1% |
| Q3 2022 | $44,282,000 | -21.7% | 715,500 | +0.8% | 0.21% | -17.3% |
| Q2 2022 | $56,590,000 | -7.7% | 709,506 | +21.8% | 0.26% | +13.8% |
| Q1 2022 | $61,307,000 | +18.3% | 582,719 | +21.2% | 0.22% | +24.4% |
| Q4 2021 | $51,815,000 | +28.4% | 480,839 | +30.5% | 0.18% | +18.4% |
| Q3 2021 | $40,365,000 | +165.1% | 368,502 | +126.6% | 0.15% | +176.4% |
| Q2 2021 | $15,227,000 | -2.8% | 162,616 | -4.5% | 0.06% | -6.8% |
| Q1 2021 | $15,667,000 | +39.5% | 170,221 | +10.9% | 0.06% | +37.2% |
| Q4 2020 | $11,231,000 | +941.8% | 153,547 | +1006.1% | 0.04% | +760.0% |
| Q3 2020 | $1,078,000 | -20.9% | 13,882 | -43.4% | 0.01% | -16.7% |
| Q2 2020 | $1,363,000 | +128.7% | 24,529 | +21.8% | 0.01% | +100.0% |
| Q1 2020 | $596,000 | -13.9% | 20,133 | +5.2% | 0.00% | 0.0% |
| Q4 2019 | $692,000 | +6.1% | 19,134 | -20.3% | 0.00% | +200.0% |
| Q3 2019 | $652,000 | +115.2% | 24,002 | +90.1% | 0.00% | 0.0% |
| Q2 2019 | $303,000 | – | 12,628 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |